[{"indications": "Indications\u00a0insomnia (short-term use\u2014up to 2 weeks)", "name": "ZALEPLON", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "4 Central nervous system", "4.1 Hypnotics and anxiolytics", "4.1.1 Hypnotics", "Zaleplon, zolpidem, and zopiclone", "ZALEPLON"], "cautions": "Cautions\u00a0respiratory insufficiency (avoid if severe); muscle weakness and myasthenia gravis, history of drug or alcohol abuse; depression (risk of suicidal ideation); avoid prolonged\r\nuse (risk of tolerance and withdrawal symptoms); interactions: Appendix 1 (anxiolytics\r\nand hypnotics)", "side-effects": "Side-effects\u00a0amnesia, paraesthesia, drowsiness; dysmenorrhea; less commonly nausea, anorexia, asthenia, incoordination,\r\nconfusion, impaired concentration, depression, depersonalisation,\r\ndizziness, hallucinations, disturbances of smell, hearing, speech,\r\nand vision; photosensitivity; paradoxical effects (see Paradoxical Effects) and sleep-walking also reported", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/85914.htm", "doses": ["adult over 18 years, 10\u00a0mg\r\nat bedtime or after going to bed if difficulty falling asleep; elderly 5\u00a0mg", "Patients should be advised not to take a\r\nsecond dose during a single night"], "pregnancy": "Pregnancy\u00a0use only if necessary and restrict to occasional\r\nshort-term use; risk of withdrawal symptoms in neonate if used in\r\nlate pregnancy"}]